Reed Elsevier NV (ADR)  

(Public, NYSE:ENL)   Watch this stock  
Find more results for ENL
-0.91 (-1.90%)
Jul 1 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 46.85 - 48.24
52 week 41.55 - 51.81
Open 48.24
Vol / Avg. 2,650.00/50,837.00
Mkt cap 16.87B
P/E 25.04
Div/yield 0.96/2.90
EPS 1.88
Shares 650.52M
Beta 1.16
Inst. own 1%
Jul 23, 2015
Half Year 2015 Reed Elsevier PLC Earnings Release - 3:00AM EDT - Add to calendar
Apr 22, 2015
Reed Elsevier NV Annual Shareholders Meeting
Apr 22, 2015
Q1 2015 Reed Elsevier PLC Trading Statement Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 17.20% 16.62%
Operating margin 24.09% 24.28%
EBITD margin - 29.14%
Return on average assets 47.33% 40.82%
Return on average equity 49.32% 42.39%
CDP Score - -


Radarweg 29
+31-20-4852222 (Phone)
+31-20-4852032 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Reed Elsevier NV is a provider of information solutions. The Company operates in four market segments: Scientific, Technical & Medical; Risk & Business Information; Legal, and Exhibitions. It operates in North America and Europe. Its products and services comprise intellectual property content delivered through various media, including online, journals and books. The Scientific, Technical & Medical segment provides information and tools to help customers in scientific and healthcare outcomes. The Risk & Business Information segment provides data and analytics that enable customers to evaluate and manage risk. The Legal segment is a provider of legal, regulatory and news and business information and analysis to law firm, corporate, Government and academic customers. The Exhibitions segment consists of Reed Exhibitions, which is an exhibitions business.

Officers and directors

Erik Engstrom Chief Executive Officer, Executive Director
Age: 51
Bio & Compensation  - Reuters
Nick L. Luff Chief Financial Officer, Executive Director
Age: 47
Bio & Compensation  - Reuters
Mark Kelsey Chief Executive Officer Risk Solutions and Business Information
Bio & Compensation  - Reuters
Ron Mobed Chief Executive Officer Scientific, Technical and Medical
Age: 55
Bio & Compensation  - Reuters
Mike Rusbridge Chief Executive Officer Exhibitions
Bio & Compensation  - Reuters
Mike Walsh Chief Executive Officer Legal
Bio & Compensation  - Reuters
Henry Adam Udow Chief Legal Officer and Company Secretary
Bio & Compensation  - Reuters
Ian Fraser Human Resources Director
Bio & Compensation  - Reuters
Kumsal Bayazit Chief Strategy Officer
Bio & Compensation  - Reuters
Youngsuk Chi Director of Corporate Affairs and Chairman Elsevier
Bio & Compensation  - Reuters